Barbier-Torres, Lucía
Fortner, Karen A.
Iruzubieta, Paula
Delgado, Teresa C.
Giddings, Emily
Chen, Youdinghuan http://orcid.org/0000-0002-5451-0482
Champagne, Devin http://orcid.org/0000-0002-1958-7433
Fernández-Ramos, David
Mestre, Daniela
Gomez-Santos, Beatriz
Varela-Rey, Marta
de Juan, Virginia Gutiérrez
Fernández-Tussy, Pablo
Zubiete-Franco, Imanol
García-Monzón, Carmelo
González-Rodríguez, Águeda
Oza, Dhaval
Valença-Pereira, Felipe
Fang, Qian
Crespo, Javier
Aspichueta, Patricia
Tremblay, Frederic
Christensen, Brock C. http://orcid.org/0000-0003-3022-426X
Anguita, Juan http://orcid.org/0000-0003-2061-7182
Martínez-Chantar, María Luz http://orcid.org/0000-0002-6446-9911
Rincón, Mercedes http://orcid.org/0000-0002-6663-2225
Article History
Received: 19 June 2019
Accepted: 4 June 2020
First Online: 3 July 2020
Competing interests
: M.R. has a patent application related to this work. M.L.M.-C. and J.A. have a patent application that could be related to this work. M.R. is a co-founder and a member of the Scientific Advisory Board of Mitotherapeutix LLC. M.L.M.-C. is a member of the Scientific Advisory Board of Mitotherapeutix LLC. K.A.F. has received funding through Mitorherapeutix. F. T. and D. O. are employees or Alnylam Pharmaceuticals with salary and stock options. The rest of the authors declare no competing interest.